Evidence map›Paper›PMID 28192433›Full record

ArticlePLoS neglected tropical diseases2017

Review of 21 cases of mycetoma from 1991 to 2014 in Rio de Janeiro, Brazil.

Felipe Maurício Soeiro Sampaio, Bodo Wanke, Dayvison Francis Saraiva Freitas, Janice Mery Chicarino de Oliveira Coelho, Maria Clara Gutierrez Galhardo, Marcelo Rosandiski Lyra, Maria Cristina da Silva Lourenço, Rodrigo de Almeida Paes, Antonio Carlos Francesconi do Valle

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Case report: Mycetoma caused by Gordonia soli.Revista da Sociedade Brasileira de Medicina Tropical · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Management of pulmonaryThe Journal of international medical research · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Mycetoma: a clinical dilemma in resource limited settings.Annals of clinical microbiology and antimicrobials · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Felipe Maurício Soeiro SampaioNational Institute of Infectious Diseases, Oswaldo Cruz Foundation - Rio de Janeiro - Brazil.ORCID 0000-0002-2235-5473
Bodo WankeNational Institute of Infectious Diseases, Oswaldo Cruz Foundation - Rio de Janeiro - Brazil.
Dayvison Francis Saraiva FreitasNational Institute of Infectious Diseases, Oswaldo Cruz Foundation - Rio de Janeiro - Brazil.
Janice Mery Chicarino de Oliveira CoelhoNational Institute of Infectious Diseases, Oswaldo Cruz Foundation - Rio de Janeiro - Brazil.
Maria Clara Gutierrez GalhardoNational Institute of Infectious Diseases, Oswaldo Cruz Foundation - Rio de Janeiro - Brazil.
Marcelo Rosandiski LyraNational Institute of Infectious Diseases, Oswaldo Cruz Foundation - Rio de Janeiro - Brazil.
Maria Cristina da Silva LourençoNational Institute of Infectious Diseases, Oswaldo Cruz Foundation - Rio de Janeiro - Brazil.
Rodrigo de Almeida PaesNational Institute of Infectious Diseases, Oswaldo Cruz Foundation - Rio de Janeiro - Brazil.
Antonio Carlos Francesconi do ValleNational Institute of Infectious Diseases, Oswaldo Cruz Foundation - Rio de Janeiro - Brazil.
Fundação Oswaldo Cruz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycetoma is caused by the subcutaneous inoculation of filamentous fungi or aerobic filamentous bacteria that form grains in the tissue. The purpose of this study is to describe the epidemiologic, clinic, laboratory, and therapeutic characteristics of patients with mycetoma at the Oswaldo Cruz Foundation in Rio de Janeiro, Brazil, between 1991 and 2014. Twenty-one cases of mycetoma were included in the study. There was a predominance of male patients (1.3:1) and the average patient age was 46 years. The majority of the cases were from the Southeast region of Brazil and the feet were the most affected anatomical region (80.95%). Eumycetoma prevailed over actinomycetoma (61.9% and 38.1% respectively). Eumycetoma patients had positive cultures in 8 of 13 cases, with isolation of Scedosporium apiospermum species complex (n = 3), Madurella mycetomatis (n = 2) and Acremonium spp. (n = 1). Two cases presented sterile mycelium and five were negative. Six of 8 actinomycetoma cases had cultures that were identified as Nocardia spp. (n = 3), Nocardia brasiliensis (n = 2), and Nocardia asteroides (n = 1). Imaging tests were performed on all but one patients, and bone destruction was identified in 9 cases (42.68%). All eumycetoma cases were treated with itraconazole monotherapy or combined with fluconazole, terbinafine, or amphotericin B. Actinomycetoma cases were treated with sulfamethoxazole plus trimethoprim or combined with cycles of amikacin sulphate. Surgical procedures were performed in 9 (69.2%) eumycetoma and in 3 (37.5%) actinomycetoma cases, with one amputation case in each group. Clinical cure occurred in 11 cases (7 for eumycetoma and 4 for actinomycetoma), and recurrence was documented in 4 of 21 cases. No deaths were recorded during the study. Despite of the scarcity of mycetoma in our institution the cases presented reflect the wide clinical spectrum and difficulties to take care of this neglected disease.

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsAntifungal AgentsBrazilChildChild, PreschoolDebridementFemaleFungiHumansInfantInfant, NewbornMaleAnti-Bacterial AgentsAntifungal Agents

Identifiers

PMID28192433
PMCPMC5336304
OpenAlexW2587912756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.